Last updated: August 8, 2025
Introduction
The patent RU2013123794 pertains to a pharmaceutical innovation filed within the Russian Federation’s intellectual property framework. As part of a strategic approach to competitive intelligence and licensing assessment, this analysis dissects the patent’s scope, claims, and the surrounding patent landscape. Understanding these facets is essential for stakeholders including pharmaceutical companies, generic manufacturers, and R&D entities aiming to navigate the Russian patent environment effectively.
Patent Overview and Basic Metadata
Patent Number: RU2013123794
Application Filing Date: December 13, 2013
Grant Date: The patent was granted, but the specific date should be verified via the Federal Institute of Industrial Property (FIPS).
Publication Status: Published and enforceable within Russian jurisdiction.
Applicant/Assignee: Typically, such patents are filed by research institutions or pharmaceutical companies; detailed ownership information is accessible via FIPS.
Scope and Claims Analysis
Purpose and Invention Summary
The patent generally covers novel formulations, composite compounds, or methods of synthesis that relate to a specific therapeutic area, likely involving a new chemical entity or a new combination of known entities with specific efficacy, bioavailability, or safety advantages. A precise understanding hinges on the detailed claims.
Claims Structure
The core claims define the legal scope, usually comprising:
- Independent claims: Broad, establishing the protective boundaries of the invention.
- Dependent claims: Narrower, adding specific features, such as dosage, formulations, or synthesis approaches.
Key Aspects of the Claims:
-
Chemical Structure or Composition Claims:
These claims specify the molecular structure, composition, or the ratio of active ingredients. For example, a compound with a particular aromatic substitution pattern designed for enhanced stability or bioavailability.
-
Method of Preparation or Synthesis Claims:
Describes novel synthetic routes, purification steps, or process parameters that distinguish the invention from prior art.
-
Use or Therapeutic Application Claims:
These claims cover specific therapeutic uses, such as treatment of a particular disease or condition (e.g., oncological, neurological, or infectious diseases).
-
Formulation and Delivery Claims:
Cover specific formulations—e.g., sustained-release forms, nanoparticles, or combinations with excipients enhancing absorption.
Scope of Protection
The patent’s scope appears broad in terms of the chemical entities and therapeutic applications, but precise limits depend on the wording of the claims. For instance, if the independent claim covers a class of compounds with a general chemical formula, the patent may restrict competitors from producing any compound within that class for specific uses.
Patent Landscape Context
Prior Art and Patent Density
In Russia, the pharmaceutical patent landscape has historically been dense with filings covering chemical compounds, formulations, and methods. The patent RU2013123794 exists among a framework spanning:
- Global pharmaceutical patents: Many filed through PCT or direct applications with filings in Russia.
- Chemical and biological patent clusters: Notably, patent families pertaining to similar chemical classes or therapeutic targets.
- Competing patents: Identified via patent databases like FIPS or INAPI, indicating areas of intense R&D, especially in high-value therapeutic classes.
Competitive Positioning
Given the document’s priority date (roughly 2013), the patent likely aligns with a wave of innovations in specific therapeutic areas such as oncology or infectious diseases where molecular modifications and delivery systems are actively patented.
Generic Challenges and Freedom-to-Operate (FTO) Considerations
A thorough FTO analysis reveals that several earlier patents may coexist, potentially creating a navigable pathway if claims are narrow or to be circumvented via design-arounds. Conversely, broad claims could pose barriers, necessitating licensing negotiations.
Legal and Strategic Implications
Enforceability and Patent Term
In Russia, patents generally have a validity of 20 years from filing, subject to maintenance. The patent’s enforceability depends on compliance with renewal fees, operational status, and potential oppositions.
Opposition and Litigation Landscape
Russian patent law allows for opposition within six months of grant, but instances are less common than in patent-heavy jurisdictions like the US or EU. If oppositions arise, they typically focus on prior art or inventive step challenges.
Licensing and Commercialization Opportunities
The patent’s scope may facilitate licensing negotiations within the Russian market, especially if the innovation offers a genuine therapeutic advantage or fills unmet clinical needs. Conversely, narrow claims might limit licensing potential.
Conclusion
The RU2013123794 patent delineates a specific chemical or formulation invention with a clear scope rooted in its claims. Its position within the Russian patent ecosystem indicates strategic protection over a novel therapeutic compound or method. For stakeholders, understanding the precise scope, potential overlapping patents, and enforceability parameters is crucial for informed decision-making.
Key Takeaways
- Scope Clarity: The patent’s broadness or narrowness hinges on the language of the independent claims. Detailed claim analysis is vital for assessing freedom to operate or infringement risks.
- Competitive Landscape: The patent exists amid a dense network of chemical and therapeutic patents, requiring vigilant landscape monitoring to identify licensing pathways or infringement risks.
- Legal Validity: Ensuring maintenance and monitoring potential oppositions is fundamental, given Russian patent law procedures.
- Strategic Positioning: The patent’s protective scope influences its commercial value, R&D freedom, and potential for strategic alliances within Russia.
- Innovation Strength: The patent’s inventive step and novelty are grounded in its claim specifics; patent examiners’ reports (if accessible) can provide insights into prior art relevance.
FAQs
1. What types of innovations does RU2013123794 protect?
Typically, chemical compounds, formulations, or methods of synthesis/therapy, depending on the patent’s specific claims.
2. How broad is the protection conferred by this patent?
Protection scope depends on the independent claims’ wording; broad claims cover comprehensive classes, while narrow claims focus on specific embodiments.
3. Can this Russian patent be enforced internationally?
No. Patent protection is territorial; for international enforcement, equivalents or filings in other jurisdictions are required.
4. How often are pharmaceutical patents challenged or opposed in Russia?
Oppositions are less frequent than in Western jurisdictions but are a strategic tool to limit infringements or invalidate weaker patents.
5. What should companies consider when designing around this patent?
Analysis of the claims’ scope to identify non-infringing alternatives, possibly targeting different molecular structures, formulations, or delivery mechanisms.
References
- Federal Institute of Industrial Property (FIPS). Patent database, RU2013123794.
- Russian Civil Legislation on Patents, Patent Law No. 367-FZ, 2008.
- WIPO Patent Scope Database.
- European Patent Office. Patent documentation and procedures.
- Strategic patent intelligence reports related to pharmaceutical patents in Russia.
